Global Anti-Neprilysin Supply, Demand and Key Producers, 2024-2030

Description

The global Anti-Neprilysin market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.

This report studies the global Anti-Neprilysin demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-Neprilysin, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-Neprilysin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-Neprilysin total market, 2019-2030, (USD Million)
Global Anti-Neprilysin total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Anti-Neprilysin total market, key domestic companies and share, (USD Million)
Global Anti-Neprilysin revenue by player and market share 2019-2024, (USD Million)
Global Anti-Neprilysin total market by Type, CAGR, 2019-2030, (USD Million)
Global Anti-Neprilysin total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Anti-Neprilysin market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited and Oceanic Pharmachem Pvt. Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-Neprilysin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-Neprilysin Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-Neprilysin Market, Segmentation by Type
    Sacubitril
    TD-0714
    STR-324
    PL-265
    LHW-090

Global Anti-Neprilysin Market, Segmentation by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Companies Profiled:
    Bioprojet SCR
    Novartis International AG
    Pharmaleads SA
    Theravance Biopharma Inc.
    Cipla Limited
    Oceanic Pharmachem Pvt. Ltd

Key Questions Answered
1. How big is the global Anti-Neprilysin market?
2. What is the demand of the global Anti-Neprilysin market?
3. What is the year over year growth of the global Anti-Neprilysin market?
4. What is the total value of the global Anti-Neprilysin market?
5. Who are the major players in the global Anti-Neprilysin market?

Table of Contents

1 Supply Summary
    1.1 Anti-Neprilysin Introduction
    1.2 World Anti-Neprilysin Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Anti-Neprilysin Total Market by Region (by Headquarter Location)
        1.3.1 World Anti-Neprilysin Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Anti-Neprilysin Market Size (2019-2030)
        1.3.3 China Anti-Neprilysin Market Size (2019-2030)
        1.3.4 Europe Anti-Neprilysin Market Size (2019-2030)
        1.3.5 Japan Anti-Neprilysin Market Size (2019-2030)
        1.3.6 South Korea Anti-Neprilysin Market Size (2019-2030)
        1.3.7 ASEAN Anti-Neprilysin Market Size (2019-2030)
        1.3.8 India Anti-Neprilysin Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-Neprilysin Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-Neprilysin Major Market Trends

2 Demand Summary
    2.1 World Anti-Neprilysin Consumption Value (2019-2030)
    2.2 World Anti-Neprilysin Consumption Value by Region
        2.2.1 World Anti-Neprilysin Consumption Value by Region (2019-2024)
        2.2.2 World Anti-Neprilysin Consumption Value Forecast by Region (2025-2030)
    2.3 United States Anti-Neprilysin Consumption Value (2019-2030)
    2.4 China Anti-Neprilysin Consumption Value (2019-2030)
    2.5 Europe Anti-Neprilysin Consumption Value (2019-2030)
    2.6 Japan Anti-Neprilysin Consumption Value (2019-2030)
    2.7 South Korea Anti-Neprilysin Consumption Value (2019-2030)
    2.8 ASEAN Anti-Neprilysin Consumption Value (2019-2030)
    2.9 India Anti-Neprilysin Consumption Value (2019-2030)

3 World Anti-Neprilysin Companies Competitive Analysis
    3.1 World Anti-Neprilysin Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Anti-Neprilysin Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Anti-Neprilysin in 2023
        3.2.3 Global Concentration Ratios (CR8) for Anti-Neprilysin in 2023
    3.3 Anti-Neprilysin Company Evaluation Quadrant
    3.4 Anti-Neprilysin Market: Overall Company Footprint Analysis
        3.4.1 Anti-Neprilysin Market: Region Footprint
        3.4.2 Anti-Neprilysin Market: Company Product Type Footprint
        3.4.3 Anti-Neprilysin Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Anti-Neprilysin Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Anti-Neprilysin Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Anti-Neprilysin Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Anti-Neprilysin Consumption Value Comparison
        4.2.1 United States VS China: Anti-Neprilysin Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-Neprilysin Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Anti-Neprilysin Companies and Market Share, 2019-2024
        4.3.1 United States Based Anti-Neprilysin Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Anti-Neprilysin Revenue, (2019-2024)
    4.4 China Based Companies Anti-Neprilysin Revenue and Market Share, 2019-2024
        4.4.1 China Based Anti-Neprilysin Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Anti-Neprilysin Revenue, (2019-2024)
    4.5 Rest of World Based Anti-Neprilysin Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Anti-Neprilysin Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Anti-Neprilysin Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-Neprilysin Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Sacubitril
        5.2.2 TD-0714
        5.2.3 STR-324
        5.2.4 PL-265
        5.2.5 LHW-090
    5.3 Market Segment by Type
        5.3.1 World Anti-Neprilysin Market Size by Type (2019-2024)
        5.3.2 World Anti-Neprilysin Market Size by Type (2025-2030)
        5.3.3 World Anti-Neprilysin Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-Neprilysin Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Anti-Neprilysin Market Size by Application (2019-2024)
        6.3.2 World Anti-Neprilysin Market Size by Application (2025-2030)
        6.3.3 World Anti-Neprilysin Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Bioprojet SCR
        7.1.1 Bioprojet SCR Details
        7.1.2 Bioprojet SCR Major Business
        7.1.3 Bioprojet SCR Anti-Neprilysin Product and Services
        7.1.4 Bioprojet SCR Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bioprojet SCR Recent Developments/Updates
        7.1.6 Bioprojet SCR Competitive Strengths & Weaknesses
    7.2 Novartis International AG
        7.2.1 Novartis International AG Details
        7.2.2 Novartis International AG Major Business
        7.2.3 Novartis International AG Anti-Neprilysin Product and Services
        7.2.4 Novartis International AG Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis International AG Recent Developments/Updates
        7.2.6 Novartis International AG Competitive Strengths & Weaknesses
    7.3 Pharmaleads SA
        7.3.1 Pharmaleads SA Details
        7.3.2 Pharmaleads SA Major Business
        7.3.3 Pharmaleads SA Anti-Neprilysin Product and Services
        7.3.4 Pharmaleads SA Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Pharmaleads SA Recent Developments/Updates
        7.3.6 Pharmaleads SA Competitive Strengths & Weaknesses
    7.4 Theravance Biopharma Inc.
        7.4.1 Theravance Biopharma Inc. Details
        7.4.2 Theravance Biopharma Inc. Major Business
        7.4.3 Theravance Biopharma Inc. Anti-Neprilysin Product and Services
        7.4.4 Theravance Biopharma Inc. Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Theravance Biopharma Inc. Recent Developments/Updates
        7.4.6 Theravance Biopharma Inc. Competitive Strengths & Weaknesses
    7.5 Cipla Limited
        7.5.1 Cipla Limited Details
        7.5.2 Cipla Limited Major Business
        7.5.3 Cipla Limited Anti-Neprilysin Product and Services
        7.5.4 Cipla Limited Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Cipla Limited Recent Developments/Updates
        7.5.6 Cipla Limited Competitive Strengths & Weaknesses
    7.6 Oceanic Pharmachem Pvt. Ltd
        7.6.1 Oceanic Pharmachem Pvt. Ltd Details
        7.6.2 Oceanic Pharmachem Pvt. Ltd Major Business
        7.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Product and Services
        7.6.4 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Oceanic Pharmachem Pvt. Ltd Recent Developments/Updates
        7.6.6 Oceanic Pharmachem Pvt. Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-Neprilysin Industry Chain
    8.2 Anti-Neprilysin Upstream Analysis
    8.3 Anti-Neprilysin Midstream Analysis
    8.4 Anti-Neprilysin Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Anti-Neprilysin Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Anti-Neprilysin Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Anti-Neprilysin Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Anti-Neprilysin Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Anti-Neprilysin Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Anti-Neprilysin Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Anti-Neprilysin Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Anti-Neprilysin Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Anti-Neprilysin Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Anti-Neprilysin Players in 2023
    Table 12. World Anti-Neprilysin Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Anti-Neprilysin Company Evaluation Quadrant
    Table 14. Head Office of Key Anti-Neprilysin Player
    Table 15. Anti-Neprilysin Market: Company Product Type Footprint
    Table 16. Anti-Neprilysin Market: Company Product Application Footprint
    Table 17. Anti-Neprilysin Mergers & Acquisitions Activity
    Table 18. United States VS China Anti-Neprilysin Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Anti-Neprilysin Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Anti-Neprilysin Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Anti-Neprilysin Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Anti-Neprilysin Revenue Market Share (2019-2024)
    Table 23. China Based Anti-Neprilysin Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Anti-Neprilysin Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Anti-Neprilysin Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Anti-Neprilysin Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Anti-Neprilysin Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Anti-Neprilysin Revenue Market Share (2019-2024)
    Table 29. World Anti-Neprilysin Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Anti-Neprilysin Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Anti-Neprilysin Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Anti-Neprilysin Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Anti-Neprilysin Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Anti-Neprilysin Market Size by Application (2025-2030) & (USD Million)
    Table 35. Bioprojet SCR Basic Information, Area Served and Competitors
    Table 36. Bioprojet SCR Major Business
    Table 37. Bioprojet SCR Anti-Neprilysin Product and Services
    Table 38. Bioprojet SCR Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Bioprojet SCR Recent Developments/Updates
    Table 40. Bioprojet SCR Competitive Strengths & Weaknesses
    Table 41. Novartis International AG Basic Information, Area Served and Competitors
    Table 42. Novartis International AG Major Business
    Table 43. Novartis International AG Anti-Neprilysin Product and Services
    Table 44. Novartis International AG Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Novartis International AG Recent Developments/Updates
    Table 46. Novartis International AG Competitive Strengths & Weaknesses
    Table 47. Pharmaleads SA Basic Information, Area Served and Competitors
    Table 48. Pharmaleads SA Major Business
    Table 49. Pharmaleads SA Anti-Neprilysin Product and Services
    Table 50. Pharmaleads SA Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Pharmaleads SA Recent Developments/Updates
    Table 52. Pharmaleads SA Competitive Strengths & Weaknesses
    Table 53. Theravance Biopharma Inc. Basic Information, Area Served and Competitors
    Table 54. Theravance Biopharma Inc. Major Business
    Table 55. Theravance Biopharma Inc. Anti-Neprilysin Product and Services
    Table 56. Theravance Biopharma Inc. Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Theravance Biopharma Inc. Recent Developments/Updates
    Table 58. Theravance Biopharma Inc. Competitive Strengths & Weaknesses
    Table 59. Cipla Limited Basic Information, Area Served and Competitors
    Table 60. Cipla Limited Major Business
    Table 61. Cipla Limited Anti-Neprilysin Product and Services
    Table 62. Cipla Limited Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Cipla Limited Recent Developments/Updates
    Table 64. Oceanic Pharmachem Pvt. Ltd Basic Information, Area Served and Competitors
    Table 65. Oceanic Pharmachem Pvt. Ltd Major Business
    Table 66. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Product and Services
    Table 67. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 68. Global Key Players of Anti-Neprilysin Upstream (Raw Materials)
    Table 69. Anti-Neprilysin Typical Customers
List of Figure
    Figure 1. Anti-Neprilysin Picture
    Figure 2. World Anti-Neprilysin Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Anti-Neprilysin Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Anti-Neprilysin Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Anti-Neprilysin Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Anti-Neprilysin Revenue (2019-2030) & (USD Million)
    Figure 13. Anti-Neprilysin Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Anti-Neprilysin Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Anti-Neprilysin Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Anti-Neprilysin by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Anti-Neprilysin Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Anti-Neprilysin Markets in 2023
    Figure 27. United States VS China: Anti-Neprilysin Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Anti-Neprilysin Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Anti-Neprilysin Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Anti-Neprilysin Market Size Market Share by Type in 2023
    Figure 31. Sacubitril
    Figure 32. TD-0714
    Figure 33. STR-324
    Figure 34. PL-265
    Figure 35. LHW-090
    Figure 36. World Anti-Neprilysin Market Size Market Share by Type (2019-2030)
    Figure 37. World Anti-Neprilysin Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Anti-Neprilysin Market Size Market Share by Application in 2023
    Figure 39. Hospital Pharmacies
    Figure 40. Retail Pharmacies
    Figure 41. Online Pharmacies
    Figure 42. Anti-Neprilysin Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd